XML 42 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2022
Stockholders Equity Note [Abstract]  
Schedule of Compensation Cost

The cost that has been charged against income for stock-based compensation is set forth below (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2022

 

 

October 1, 2021

 

 

September 30, 2022

 

 

October 1, 2021

 

Employee stock options

 

$

2,865

 

 

$

2,594

 

 

$

7,649

 

 

$

7,850

 

Restricted stock

 

 

67

 

 

 

109

 

 

 

618

 

 

 

507

 

Restricted stock units

 

 

1,249

 

 

 

700

 

 

 

3,242

 

 

 

2,048

 

Performance stock units

 

 

1,240

 

 

 

124

 

 

 

2,932

 

 

 

325

 

Nonemployee stock options

 

 

306

 

 

 

136

 

 

 

934

 

 

 

255

 

Total stock-based compensation expense

 

$

5,727

 

 

$

3,663

 

 

$

15,375

 

 

$

10,985

 

 

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The Company recorded stock-based compensation costs in the following categories (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2022

 

 

October 1, 2021

 

 

September 30, 2022

 

 

October 1, 2021

 

Cost of sales

 

$

233

 

 

$

61

 

 

$

409

 

 

$

150

 

General and administrative

 

 

2,584

 

 

 

1,671

 

 

 

7,171

 

 

 

4,925

 

Selling and marketing

 

 

1,335

 

 

 

851

 

 

 

3,548

 

 

 

2,637

 

Research and development

 

 

1,575

 

 

 

1,080

 

 

 

4,247

 

 

 

3,273

 

Total stock-based compensation expense, net

 

 

5,727

 

 

 

3,663

 

 

 

15,375

 

 

 

10,985

 

Amounts capitalized as part of inventory

 

 

361

 

 

 

383

 

 

 

1,379

 

 

 

1,082

 

Total stock-based compensation expense, gross

 

$

6,088

 

 

$

4,046

 

 

$

16,754

 

 

$

12,067

 

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2022

 

 

October 1, 2021

 

 

September 30, 2022

 

 

October 1, 2021

 

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

Expected volatility

 

 

54

%

 

 

53

%

 

 

54

%

 

 

53

%

Risk-free interest rate

 

 

2.91

%

 

 

0.79

%

 

 

1.88

%

 

 

0.84

%

Expected term (in years)

 

 

5.10

 

 

 

5.38

 

 

 

5.10

 

 

 

5.38

 

 

Schedule of Share-based Compensation, Stock Options, Activity

A summary of stock option activity under the Plan for nine months ended September 30, 2022 is presented below:

 

 

 

Stock

Options

(in 000’s)

 

 

Minimum

Exercise

Price

 

 

Maximum

Exercise

Price

 

Outstanding at December 31, 2021

 

 

2,435

 

 

 

 

 

 

 

 

 

Granted

 

 

443

 

 

 

 

 

 

 

 

 

Exercised

 

 

(417

)

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(23

)

 

 

 

 

 

 

 

 

Outstanding at September 30, 2022

 

 

2,438

 

 

$

5.34

 

 

$

154.96

 

Exercisable at September 30, 2022

 

 

1,778

 

 

 

 

 

 

 

 

 

 

Schedule of Share-based Compensation, Restricted Stock, RSUs and PSUs Activity

A summary of restricted stock, RSUs and PSUs activity under the Plan for the nine months ended September 30, 2022 is presented below (shares in thousands):

 

 

 

Restricted

Stock

 

 

RSUs

 

 

PSUs

 

Unvested at December 31, 2021

 

 

3

 

 

 

131

 

 

 

10

 

Granted

 

 

6

 

 

 

116

 

 

 

113

 

Vested

 

 

(5

)

 

 

(57

)

 

 

(5

)

Unvested at September 30, 2022

 

 

4

 

 

 

190

 

 

 

118